Literature DB >> 31410487

Human osteoarthritic synovial fluid increases excitability of mouse dorsal root ganglion sensory neurons: an in-vitro translational model to study arthritic pain.

Sampurna Chakrabarti1, Deepak R Jadon2,3, David C Bulmer1, Ewan St John Smith1.   

Abstract

OBJECTIVES: Knee OA is a leading global cause of morbidity. This study investigates the effects of knee SF from patients with OA on the activity of dorsal root ganglion sensory neurons that innervate the knee (knee neurons) as a novel translational model of disease-mediated nociception in human OA.
METHODS: Dissociated cultures of mouse knee neurons were incubated overnight or acutely stimulated with OA-SF (n = 4) and fluid from healthy donors (n = 3, Ctrl-SF). Electrophysiology and Ca2+-imaging determined changes in electrical excitability and transient receptor potential channel function, respectively.
RESULTS: Incubation with OA-SF induced knee neuron hyperexcitability compared to Ctrl-SF: the resting membrane potential significantly increased (F(2, 92) = 5.6, P = 0.005, ANOVA) and the action potential threshold decreased (F(2, 92) = 8.8, P = 0.0003, ANOVA); TRPV1 (F(2, 445) = 3.7, P = 0.02) and TRPM8 (F(2, 174) = 11.1, P < 0.0001, ANOVA) channel activity also increased. Acute application of Ctrl-SF and OA-SF increased intracellular Ca2+ concentration via intra- and extracellular Ca2+ sources.
CONCLUSION: Human OA-SF acutely activated knee neurons and induced hyperexcitability indicating that mediators present in OA-SF stimulate sensory nerve activity and thereby give rise to knee pain. Taken together, this study provides proof-of-concept for a new method to study the ability of mediators present in joints of patients with arthritis to stimulate nociceptor activity and hence identify clinically relevant drug targets for treating knee pain.
© The Author(s) 2019. Published by Oxford University Press on behalf of the British Society for Rheumatology.

Entities:  

Keywords:  inflammation; knee osteoarthritis; neuron; pain; synovial fluid

Mesh:

Year:  2020        PMID: 31410487     DOI: 10.1093/rheumatology/kez331

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  6 in total

Review 1.  The Genesis of Pain in Osteoarthritis: Inflammation as a Mediator of Osteoarthritis Pain.

Authors:  Matthew J Wood; Rachel E Miller; Anne-Marie Malfait
Journal:  Clin Geriatr Med       Date:  2022-05       Impact factor: 3.529

2.  Pre- and Post-Interventional Changes in Physiological Profiles in a Patient Presenting With Opioid Withdrawal After Intrathecal Drug Delivery System Failure Related to Assumed Catheter Microfracture.

Authors:  Reza Ehsanian; Eugene Koshkin; Aleyah E Goins; Marena A Montera; Sascha Alles
Journal:  Cureus       Date:  2021-05-04

3.  Liraglutide, a glucagon-like peptide 1 receptor agonist, exerts analgesic, anti-inflammatory and anti-degradative actions in osteoarthritis.

Authors:  C Meurot; C Martin; L Sudre; J Breton; C Bougault; R Rattenbach; K Bismuth; C Jacques; F Berenbaum
Journal:  Sci Rep       Date:  2022-01-28       Impact factor: 4.379

4.  Functional Characterization of Ovine Dorsal Root Ganglion Neurons Reveal Peripheral Sensitization after Osteochondral Defect.

Authors:  Sampurna Chakrabarti; Minji Ai; Katherine Wong; Karin Newell; Frances M D Henson; Ewan St John Smith
Journal:  eNeuro       Date:  2021-10-13

Review 5.  Peripheral mechanisms of arthritic pain: A proposal to leverage large animals for in vitro studies.

Authors:  Sampurna Chakrabarti; Minji Ai; Frances M D Henson; Ewan St John Smith
Journal:  Neurobiol Pain       Date:  2020-07-28

6.  Differential Metabotypes in Synovial Fibroblasts and Synovial Fluid in Hip Osteoarthritis Patients Support Inflammatory Responses.

Authors:  Hussein Farah; Susanne N Wijesinghe; Thomas Nicholson; Fawzeyah Alnajjar; Michelangelo Certo; Abdullah Alghamdi; Edward T Davis; Stephen P Young; Claudio Mauro; Simon W Jones
Journal:  Int J Mol Sci       Date:  2022-03-17       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.